Accelerate Diagnostics EBITDA 2010-2024 | AXDX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Accelerate Diagnostics ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Accelerate Diagnostics ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$233.5B
Intuitive Surgical (ISRG)	$174.1B
Alcon (ALC)	$48.6B
IQVIA Holdings (IQV)	$43.5B
Edwards Lifesciences (EW)	$41.3B
IDEXX Laboratories (IDXX)	$41.2B
DexCom (DXCM)	$27.9B
STERIS (STE)	$24.1B
SONOVA HOLDING (SONVY)	$21.4B
Waters (WAT)	$19.3B
Hologic (HOLX)	$18.8B
Fresenius Medical Care AG KGaA (FMS)	$12.4B
Sysmex ADR (SSMXY)	$12.4B
Teleflex (TFX)	$11.6B
Globus Medical (GMED)	$9.4B
Penumbra (PEN)	$7.3B
Glaukos (GKOS)	$6.9B
Masimo (MASI)	$6B
TransMedics (TMDX)	$5.1B
Integer Holdings (ITGR)	$4.3B
PROCEPT BioRobotics (PRCT)	$4.2B
Tandem Diabetes Care (TNDM)	$2.9B
Inari Medical (NARI)	$2.7B
LivaNova (LIVN)	$2.6B
Veracyte (VCYT)	$2.5B
Nihon Kohden (NHNKY)	$2.5B
Elekta AB (EKTAY)	$2.5B
RxSight (RXST)	$2B
Integra LifeSciences Holdings (IART)	$1.4B
Pulse Biosciences (PLSE)	$1.1B